Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INVO Fertility, Inc.IVF · Entity 8473 | Director | August 26, 2025 | August 28, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INVO Fertility, Inc.
Report date August 26, 2025 · Filed August 28, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2035-08-26 | Direct | 45,143 |
Reported balance
After 2025-08-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-08-26 · Grant · Acquired 45,000 · Balance 45,143 F1: The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested. |
| Common StockSEC Table I · non-derivative | Direct | 33 |
Reported balance
Holding disclosure · report date 2025-08-26 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 33 |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2025 Filed Aug 28, 2025 21:18 UTC | INVO Fertility, Inc. IVF · Entity 8473 | GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0001641172-25-025867 · ownership.xml · derivative · entry 2 Messina Rebecca · CIK 0001859381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,143 Underlying: Common Stock · 45,000 shares Expires 2035-08-26 F1 · derivative.exercise_date: The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested. Read SEC document |
| May 18, 2023 Filed May 22, 2023 20:04 UTC | INVO Fertility, Inc. INVO · Entity 8473 | GrantStock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001493152-23-018623 · ownership.xml · derivative · entry 1 Messina Rebecca · CIK 0001859381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: The option vests in four equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 18:45 UTC | INVO Fertility, Inc. INVO · Entity 8473 | PurchaseCommon Stock | 9,868 | $0.95 | $9,374.60 |
DisclosureSEC source: 0001493152-22-015905 · ownership.xml · nonDerivative · entry 1 Messina Rebecca · CIK 0001859381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,045 Read SEC document |
| January 15, 2022 Filed Jan 18, 2022 21:27 UTC | INVO Fertility, Inc. INVO · Entity 8473 | GrantStock Option · Derivative | 10,098 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001493152-22-001530 · ownership.xml · derivative · entry 2 Messina Rebecca · CIK 0001859381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,098 Underlying: Common Stock · 10,098 shares Expires 2032-01-14 F1 · derivative.exercise_date: The stock option vests in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| January 15, 2022 Filed Jan 18, 2022 21:27 UTC | INVO Fertility, Inc. INVO · Entity 8473 | GrantCommon Stock | 8,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-001530 · ownership.xml · nonDerivative · entry 1 Messina Rebecca · CIK 0001859381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,177 Read SEC document |
| May 11, 2021 Filed May 13, 2021 21:10 UTC | INVO Fertility, Inc. INVO · Entity 8473 | GrantStock Option · Derivative | 6,239 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001493152-21-011367 · ownership.xml · derivative · entry 2 Messina Rebecca · CIK 0001859381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,239 Underlying: Common Stock · 6,239 shares Expires 2026-05-11 F2 · derivative.exercise_date: The option vests in substantially equal monthly increments over a period of seven months from the grant date. Read SEC document |
| May 11, 2021 Filed May 13, 2021 21:10 UTC | INVO Fertility, Inc. INVO · Entity 8473 | GrantCommon Stock | 4,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-011367 · ownership.xml · nonDerivative · entry 1 Messina Rebecca · CIK 0001859381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,806 F1 · shares: Represents an award of restricted stock units, which vest in substantially equal monthly increments over a period of seven months from the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.